Fund Holdings — Atlas Venture Life Science Advisors, LLC

Total Portfolio Value:
$1.08B
Total Bought:
$0
Total Sold:
$92.52M
Net Transaction:
-$92.52M
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Dyne Therapeutics, Inc.(DYN)8,020,1368,020,1360$283.03M$288.08M26.71%+$5.05M
Kymera Therapeutics, Inc.(KYMR)5,350,4224,896,462-453,960$159.71M$231.75M21.48%+$72.04M
Third Harmonic Bio, Inc.10,907,85910,907,8590$141.80M$147.80M13.70%+$6.00M
Disc Medicine, Inc.(IRON)2,509,4562,509,4560$113.10M$123.31M11.43%+$10.21M
Q32 Bio Inc.(QTTB)2,092,1062,092,1060$37.55M$93.35M8.65%+$55.80M
Day One Biopharmaceuticals, Inc.
COM
6,430,2576,430,2570$88.61M$89.57M8.30%+$964.5K
Korro Bio, Inc.(KRRO)1,137,1491,137,1490$38.52M$38.00M3.52%-$511.7K
Generation Bio, Co.8,279,4848,279,4840$23.35M$20.45M1.90%-$2.90M
Vigil Neuroscience, Inc.5,836,8745,836,8740$23.35M$19.85M1.84%-$3.50M
Tectonic Therapeutic, Inc.(TECX)378,447378,4470$6.23M$11.47M1.06%+$5.23M
Ikena Oncology, Inc.5,018,1785,018,1780$8.28M$8.68M0.80%+$401.5K
Aerovate Therapeutics, Inc.1,799,2321,799,2320$2.99M$3.76M0.35%+$773.7K
Dianthus Therapeutics, Inc.(DNTH)136,97976,979-60,000$3.55M$2.11M0.20%-$1.44M
Spero Therapeutics, Inc.(SPRO)535,336402,885-132,451$695.9K$539.9K0.05%-$156.1K
Replimune Group, Inc.(REPL)2,098,3000-2,098,300$18.88M$0—-$18.88M
Page 1 of 1
Atlas Venture Life Science Advisors, LLC — 13F Holdings — Q3 2024 | TickerTrail